Latest News

April 21, 2005
The campus community is invited to hear national health expert, Dean Ornish, MD, clinical professor of medicine at UCSF, who will discuss how his pioneering scientific research has reversed and prevented chronic illnesses and how lifestyle changes can improve health and quality of life.
April 21, 2005
Rights and responsibilities are at the heart of the conscience clause debate, which in recent months has crystallized around two questions.
April 20, 2005
Professor Jonathan A. Showstack has been appointed Academic Information Technology Coordinator in the UCSF Office of the Executive Vice Chancellor.
April 20, 2005
The campus community is invited to a ceremony honoring two of UCSF's top teachers, Tracy B. Fulton, PhD, and Martin S. Bogetz, MD, who will be presented the 2004-2005 UCSF Distinction in Teaching Awards on Thursday, April 28.
April 19, 2005
UCSF will join a public/private partnership that will train disadvantaged students at City College of San Francisco for jobs in stem cell research.
April 19, 2005
Lewis T. "Rusty" Williams, founder and executive chairman of FivePrime Therapeutics Inc., will be the keynote speaker at tonight's (April 19) Scientist to CEO event at UCSF Mission Bay.
April 18, 2005
So-called "conscience clauses" -- which allow pharmacists to refuse to dispense drugs for moral or religious reasons -- have now become the latest flashpoint between "right-to-life" advocates and those with a broader view of a pharmacist's responsibilities.
April 18, 2005
Attention all employees of the UCSF workforce who use, create, transmit, store or confidential, electronic patient information: the Security Rule of the Health Insurance Portability and Accountability Act (HIPAA) goes into effect on Wednesday, April 20.
April 18, 2005
The campus community is invited to hear Mark Smith, CEO and president of the California HealthCare Foundation, who will address "Advocacy for Access and Cost Control in Health Care: We Have Met the Enemy and It Is Us" next week.
April 15, 2005
People with "mild persistent asthma" appear to gain adequate relief by inhaling anti-inflammatory steroids only during periods of bad symptoms, rather than daily as current guidelines recommend, a new study shows.

Pages